Topic: Development of new medicines and clinical trials; Pharmacovigilance
MD with Ph. Ds in Endocrinology and Pharmacology. After his graduation, he undertook an academic activity at the University of Turin where was appointed assistant physician at the Chair of medical Clinics and Therapeutics of the Division of Internal Medicine at S.Luigi Hospital of Turin. In 1990, he started his career as a pharmaceutical physician since the foundation of VI.REL Pharma in 1997, following the increasing request of experienced professionals in the Regulatory Affairs sector and in the clinical development of pharmaceutical companies.
Paolo Biffignandi is an author of more than 160 scientific articles in Endocrinology, Internal Medicine, Diabetology, Pharmacology, and Regulatory Affairs. He participated as invited speaker to major international symposiums on the European Pharmaceutical Legislation. He is a member of the most eminent European societies in the field among which AFI and SIAR in Italy and EMWA, RAPS, DIA, and TOPRA at the international level.
He has been founder and Editor-in-Chief of the journal TOPRA Rapporteur, member of the Board of Directors of TOPRA from 2004 to 2011 and President from 2009 to 2011.